Sana Biotechnology Inc (SANA) — Financial Flexibility Index
Sana Biotechnology Inc (SANA) has a Financial Flexibility Index of -0.11x as of June 2026. Free cash flow of $-31.17 Million (operating CF $-32.79 Million minus capex $1.62 Million) represents 0% of total liabilities ($276.95 Million). Check SANA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sana Biotechnology Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Sana Biotechnology Inc across 8 annual periods. For the full cash flow conversion analysis, see SANA cash flow conversion.
Annual Financial Flexibility Index for Sana Biotechnology Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Sana Biotechnology Inc. Explore Sana Biotechnology Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.56x | $-142.89 Million | $-143.83 Million | $256.01 Million | ▲ +26.3% |
| 2024 | -0.76x | $-189.72 Million | $-223.15 Million | $250.52 Million | ▲ +9.9% |
| 2023 | -0.84x | $-233.55 Million | $-253.58 Million | $277.79 Million | ▼ -1.0% |
| 2022 | -0.83x | $-269.17 Million | $-290.05 Million | $323.40 Million | ▼ -50.9% |
| 2021 | -0.55x | $-221.19 Million | $-251.05 Million | $400.90 Million | ▼ -456.8% |
| 2020 | -0.10x | $-114.11 Million | $-137.98 Million | $1.15 Billion | ▲ +6.8% |
| 2019 | -0.11x | $-59.32 Million | $-85.50 Million | $557.73 Million | ▲ +61.2% |
| 2018 | -0.27x | $-13.04 Million | $-13.49 Million | $47.52 Million | — |